STAAR Surgical CompanySTAANASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q1 2026 |
|---|---|---|---|---|---|
| Revenue Growth | -35.82% | -44.94% | -55.23% | +6.93% | +18.08% |
| Gross Profit Growth | -47.88% | -54.12% | -58.17% | +13.71% | +34.00% |
| EBITDA Growth | -319.81% | +0.00% | -269.46% | +255.45% | +0.00% |
| Operating Income Growth | -368.24% | +0.00% | -351.84% | +225.41% | +0.00% |
| Net Income Growth | -541.31% | +0.00% | -327.84% | -10.98% | +0.00% |
| EPS Growth | -531.25% | +0.00% | -326.67% | -10.00% | +0.00% |
| EPS Diluted Growth | -531.25% | +0.00% | -326.67% | -10.00% | +0.00% |
| Weighted Average Shares Growth | +0.92% | +0.89% | +0.80% | +0.65% | +0.61% |
| Weighted Average Shares Diluted Growth | +0.05% | +0.89% | -0.58% | -0.42% | +0.61% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -97.99% | -126.45% | +0.00% | -30.11% | -709.66% |
| Free Cash Flow Growth | -117.60% | -143.71% | +0.00% | -88.30% | +0.00% |
| Receivables Growth | -19.10% | -36.93% | -61.26% | -41.13% | -31.11% |
| Inventory Growth | +23.27% | +24.78% | +35.19% | +32.06% | +28.15% |
| Asset Growth | +4.26% | -7.14% | -14.62% | -15.11% | -9.40% |
| Book Value per Share Growth | +2.01% | -11.69% | -18.38% | -17.90% | -13.90% |
| Debt Growth | +8.12% | +2.75% | +11.71% | -2.21% | -1.01% |
| R&D Expense Growth | +10.82% | +2.12% | -13.52% | -36.48% | -24.91% |
| SG&A Expenses Growth | +20.43% | -1.72% | -13.53% | -8.45% | -6.88% |